Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 322

1.

Complete Surgical Metastasectomy for Renal Cell Carcinoma in the Post-cytokine Era.

Lyon TD, Thompson RH, Shah PH, Lohse CM, Boorjian SA, Costello BA, Cheville JC, Leibovich BC.

J Urol. 2019 Aug 8:101097JU0000000000000488. doi: 10.1097/JU.0000000000000488. [Epub ahead of print]

PMID:
31393812
2.

Long-Term Outcomes of Patients With Low Grade Cystic Renal Epithelial Neoplasms.

Westerman ME, Cheville JC, Lohse CM, Sharma V, Boorjian SA, Leibovich BC, Thompson RH.

Urology. 2019 Jul 26. pii: S0090-4295(19)30652-1. doi: 10.1016/j.urology.2019.07.017. [Epub ahead of print]

PMID:
31356826
3.

Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC.

Gupta S, Swanson AA, Chen YB, Lopez T, Milosevic D, Kipp BR, Leibovich BC, Thompson RH, Herrera-Hernandez L, Cheville JC, Jimenez RE.

Hum Pathol. 2019 Sep;91:114-122. doi: 10.1016/j.humpath.2019.07.004. Epub 2019 Jul 9.

PMID:
31299266
4.

Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.

Russell SJ, Babovic-Vuksanovic D, Bexon A, Cattaneo R, Dingli D, Dispenzieri A, Deyle DR, Federspiel MJ, Fielding A, Galanis E, Lacy MQ, Leibovich BC, Liu MC, Muñoz-Alía M, Miest TC, Molina JR, Mueller S, Okuno SH, Packiriswamy N, Peikert T, Raffel C, Van Rhee F, Ungerechts G, Young PR, Zhou Y, Peng KW.

Mayo Clin Proc. 2019 Sep;94(9):1834-1839. doi: 10.1016/j.mayocp.2019.05.006. Epub 2019 Jun 22. Review.

5.

Reply to Takeshi Takahashi's Letter to the Editor re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting functional outcomes after partial and radical nephrectomy. Eur Urol 2019;75:766-72. Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?

Bhindi B, Lohse CM, Schulte PJ, Mason RJ, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.

Eur Urol. 2019 Sep;76(3):e67-e68. doi: 10.1016/j.eururo.2019.05.033. Epub 2019 Jun 2. No abstract available.

PMID:
31167750
6.

Systematic Review of the Management of Local Kidney Cancer Relapse.

Kriegmair MC, Bertolo R, Karakiewicz PI, Leibovich BC, Ljungberg B, Mir MC, Ouzaid I, Salagierski M, Staehler M, van Poppel H, Wood CC, Capitanio U; Young Academic Urologists Kidney Cancer working group of the European Association of Urology.

Eur Urol Oncol. 2018 Dec;1(6):512-523. doi: 10.1016/j.euo.2018.06.007. Epub 2018 Jul 13. Review.

PMID:
31158097
7.

Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.

Andrews JR, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.

Eur Urol. 2019 Aug;76(2):244-251. doi: 10.1016/j.eururo.2019.04.026. Epub 2019 May 3.

PMID:
31060824
8.

Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review.

Ouzaid I, Capitanio U, Staehler M, Wood CG, Leibovich BC, Ljungberg B, Van Poppel H, Bensalah K; Young Academic Urologists Kidney Cancer Working Group of the European Association of Urology.

Eur Urol Oncol. 2019 Mar;2(2):141-149. doi: 10.1016/j.euo.2018.08.028. Epub 2018 Sep 24. Review.

PMID:
31017089
9.

JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management.

Gupta S, Cheville JC, Jungbluth AA, Zhang Y, Zhang L, Chen YB, Tickoo SK, Fine SW, Gopalan A, Al-Ahmadie HA, Sirintrapun SJ, Blum KA, Lohse CM, Hakimi AA, Thompson RH, Leibovich BC, Berger MF, Arcila ME, Ross DS, Ladanyi M, Antonescu CR, Reuter VE.

Mod Pathol. 2019 Sep;32(9):1344-1358. doi: 10.1038/s41379-019-0269-x. Epub 2019 Apr 17.

PMID:
30996253
10.

The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

Patel HD, Puligandla M, Shuch BM, Leibovich BC, Kapoor A, Master VA, Drake CG, Heng DY, Lara PN, Choueiri TK, Maskens D, Singer EA, Eggener SE, Svatek RS, Stadler WM, Cole S, Signoretti S, Gupta RT, Michaelson MD, McDermott DF, Cella D, Wagner LI, Haas NB, Carducci MA, Harshman LC, Allaf ME.

Future Oncol. 2019 May;15(15):1683-1695. doi: 10.2217/fon-2018-0951. Epub 2019 Apr 10.

PMID:
30968729
11.

Association of Partial versus Radical Nephrectomy with Subsequent Hypertension Risk Following Renal Tumor Resection.

Shah PH, Leibovich BC, Van Houten H, Lyon TD, Yao X, Knoedler M, Sangaralingham L, Kattah A, Thompson RH, Shah ND, Boorjian SA.

J Urol. 2019 Jul;202(1):69-75. doi: 10.1097/JU.0000000000000171. Epub 2019 Jun 7.

PMID:
30925222
12.

The adjuvant treatment of kidney cancer: a multidisciplinary outlook.

Porta C, Cosmai L, Leibovich BC, Powles T, Gallieni M, Bex A.

Nat Rev Nephrol. 2019 Jul;15(7):423-433. doi: 10.1038/s41581-019-0131-x. Review.

PMID:
30914797
13.

Partial Versus Radical Nephrectomy for the Clinical T1a Renal Mass.

Gershman B, Leibovich BC, Kim SP.

Eur Urol Focus. 2019 Feb 15. pii: S2405-4569(19)30025-2. doi: 10.1016/j.euf.2019.02.005. [Epub ahead of print]

PMID:
30777722
14.

Wide Variation in Opioid Prescribing After Urological Surgery in Tertiary Care Centers.

Ziegelmann MJ, Joseph JP, Glasgow AE, Tyson MD, Pak RW, Gazelka HM, Schatz AL, Leibovich BC, Habermann EB, Gettman MT.

Mayo Clin Proc. 2019 Feb;94(2):262-274. doi: 10.1016/j.mayocp.2018.08.035.

PMID:
30711124
15.

Frequency and Predictors of Renal Transplantation Among Patients Rendered Surgically Anephric for Sporadic Renal Cancer.

Boswell TC, Sharma V, Westerman ME, Dean PG, Chow GK, Thompson RH, Leibovich BC, Boorjian SA.

Urology. 2019 Apr;126:134-139. doi: 10.1016/j.urology.2018.12.037. Epub 2019 Jan 12.

PMID:
30648561
16.

Patient-Reported Outcomes After Percutaneous Renal Ablation: Initial Experience.

Atwell TD, Schultz GG, Leibovich BC, Schmit GD, Boorjian SA, Kurup AN, Thompson RH, Yost KJ.

AJR Am J Roentgenol. 2019 Mar;212(3):672-676. doi: 10.2214/AJR.17.19463. Epub 2019 Jan 8.

PMID:
30620680
17.

Renal hypothermia during partial nephrectomy for patients with renal tumours: a randomised controlled clinical trial protocol.

Breau RH, Cagiannos I, Knoll G, Morash C, Cnossen S, Lavallée LT, Mallick R, Finelli A, Jewett M, Leibovich BC, Cook J, LeBel L, Kapoor A, Pouliot F, Izawa J, Rendon R, Fergusson DA.

BMJ Open. 2019 Jan 3;9(1):e025662. doi: 10.1136/bmjopen-2018-025662.

18.

The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study.

Johansson M, Carreras-Torres R, Scelo G, Purdue MP, Mariosa D, Muller DC, Timpson NJ, Haycock PC, Brown KM, Wang Z, Ye Y, Hofmann JN, Foll M, Gaborieau V, Machiela MJ, Colli LM, Li P, Garnier JG, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Radojevic-Skodric S, Ognjanovic S, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Benhamou S, Cancel-Tassin G, Cussenot O, Weiderpass E, Ljungberg B, Tumkur Sitaram R, Häggström C, Bruinsma F, Jordan SJ, Severi G, Winship I, Hveem K, Vatten LJ, Fletcher T, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Andreotti G, Beane Freeman LE, Koutros S, Männistö S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Wilson KM, Gaziano JM, Sesso HD, Freedman ND, Parker AS, Eckel-Passow JE, Huang WY, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Eisen T, Henrion M, Larkin J, Barman P, Leibovich BC, Choueiri TK, Lathrop GM, Deleuze JF, Gunter M, McKay JD, Wu X, Houlston RS, Chanock SJ, Relton C, Richards JB, Martin RM, Davey Smith G, Brennan P.

PLoS Med. 2019 Jan 3;16(1):e1002724. doi: 10.1371/journal.pmed.1002724. eCollection 2019 Jan.

19.

Predicting Renal Function Outcomes After Partial and Radical Nephrectomy.

Bhindi B, Lohse CM, Schulte PJ, Mason RJ, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.

Eur Urol. 2019 May;75(5):766-772. doi: 10.1016/j.eururo.2018.11.021. Epub 2018 Nov 23.

PMID:
30477983
20.

Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma.

Rieken M, Boorjian SA, Kluth LA, Capitanio U, Briganti A, Thompson RH, Leibovich BC, Krabbe LM, Margulis V, Raman JD, Regelman M, Karakiewicz PI, Rouprêt M, Abufaraj M, Foerster B, Gönen M, Shariat SF.

World J Urol. 2019 Aug;37(8):1631-1637. doi: 10.1007/s00345-018-2555-5. Epub 2018 Nov 7.

21.

Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.

Gershman B, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC.

Eur Urol. 2018 Dec;74(6):825-832. doi: 10.1016/j.eururo.2018.08.028. Epub 2018 Sep 24.

PMID:
30262341
22.

Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era.

Lyon TD, Gershman B, Shah PH, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC.

Urol Oncol. 2018 Nov;36(11):499.e1-499.e7. doi: 10.1016/j.urolonc.2018.08.008. Epub 2018 Sep 15.

PMID:
30228096
23.

Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma.

Shah PH, Lyon TD, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA, Thompson RH.

BJU Int. 2019 Feb;123(2):270-276. doi: 10.1111/bju.14523. Epub 2018 Sep 9.

PMID:
30113768
24.

Predictors of Scholarly Productivity, Pursuit of Fellowship, and Academic Practice Among Urology Residents Using Medical Student Application Materials.

Thompson RH, Lohse CM, Husmann DA, Leibovich BC, Gettman MT.

Urology. 2018 Oct;120:49-55. doi: 10.1016/j.urology.2018.07.016. Epub 2018 Jul 19.

PMID:
30031833
25.

The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.

Bhindi B, Thompson RH, Lohse CM, Mason RJ, Frank I, Costello BA, Potretzke AM, Hartman RP, Potretzke TA, Boorjian SA, Cheville JC, Leibovich BC.

Eur Urol. 2018 Oct;74(4):489-497. doi: 10.1016/j.eururo.2018.06.003. Epub 2018 Jul 13.

PMID:
30017400
26.

The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass.

Shah PH, Alom MA, Leibovich BC, Thompson RH, Uzzo RG, Kavoussi LR, Richstone L, Bhindi B, Habermann EB, Joshi V, Boorjian SA.

J Urol. 2018 Nov;200(5):981-988. doi: 10.1016/j.juro.2018.05.081. Epub 2018 May 22.

PMID:
29792881
27.

Clinical and Pathology Findings Associate Consistently with Larger Glomerular Volume.

Denic A, Mathew J, Nagineni VV, Thompson RH, Leibovich BC, Lerman LO, Lieske JC, Alexander MP, Augustine JJ, Kremers WK, Rule AD.

J Am Soc Nephrol. 2018 Jul;29(7):1960-1969. doi: 10.1681/ASN.2017121305. Epub 2018 May 22. Erratum in: J Am Soc Nephrol. 2018 Sep;29(9):2445.

28.

Symptomatic Venous Thromboembolism is Associated with Inferior Survival among Patients Undergoing Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma.

Shah PH, Thompson RH, Boorjian SA, Lohse CM, Lyon TD, Shields RC, Froehling D, Leibovich BC, Viers BR.

J Urol. 2018 Sep;200(3):520-527. doi: 10.1016/j.juro.2018.04.069. Epub 2018 Apr 27.

PMID:
29709665
29.

Correlation of Online Physician Reviews and Overall Patient Satisfaction.

Leibovich BC.

Mayo Clin Proc. 2018 Apr;93(4):404-405. doi: 10.1016/j.mayocp.2018.02.021. No abstract available.

PMID:
29622094
30.

Synchronous nephron-sparing approaches for bilateral renal masses: peri-operative and renal functional outcomes.

Mason RJ, Atwell T, Lohse C, Bhindi B, Schmit G, Schmitz J, Leibovich BC, Boorjian SA, Thompson RH.

BJU Int. 2018 Aug;122(2):243-248. doi: 10.1111/bju.14221. Epub 2018 Apr 29.

31.

Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma.

Bhindi B, Habermann EB, Mason RJ, Costello BA, Pagliaro LC, Thompson RH, Leibovich BC, Boorjian SA.

J Urol. 2018 Sep;200(3):528-534. doi: 10.1016/j.juro.2018.03.077. Epub 2018 Mar 21.

PMID:
29574109
32.

Reply by the Authors.

Thompson RH, Lohse CM, Husmann DA, Leibovich BC, Gettman MT.

Urology. 2018 May;115:190. doi: 10.1016/j.urology.2018.02.001. Epub 2018 Mar 12. No abstract available.

PMID:
29545040
33.

The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus.

Hutchinson R, Rew C, Chen G, Woldu S, Krabbe LM, Meissner M, Sheth K, Singla N, Shakir N, Master VA, Karam JA, Matin SF, Borregales LD, Wood C, Masterson T, Thompson RH, Boorjian SA, Leibovich BC, Abel EJ, Bagrodia A, Margulis V.

Urology. 2018 May;115:119-124. doi: 10.1016/j.urology.2018.02.019. Epub 2018 Feb 27.

PMID:
29499258
34.
35.

Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.

Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP.

Eur Urol. 2018 May;73(5):772-780. doi: 10.1016/j.eururo.2018.01.005. Epub 2018 Feb 3.

PMID:
29398265
36.

The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis.

Bhindi B, Wallis CJD, Boorjian SA, Thompson RH, Farrell A, Kim SP, Karam JA, Capitanio U, Golijanin D, Leibovich BC, Gershman B.

BJU Int. 2018 May;121(5):684-698. doi: 10.1111/bju.14127. Epub 2018 Mar 1.

37.

Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.

Gershman B, Thompson RH, Boorjian SA, Larcher A, Capitanio U, Montorsi F, Carenzi C, Bertini R, Briganti A, Lohse CM, Cheville JC, Leibovich BC.

J Urol. 2018 May;199(5):1143-1148. doi: 10.1016/j.juro.2017.11.114. Epub 2017 Dec 7.

PMID:
29225056
38.

Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?

Figlin RA, Leibovich BC, Stewart GD, Negrier S.

Ann Oncol. 2018 Feb 1;29(2):324-331. doi: 10.1093/annonc/mdx743. Review.

PMID:
29186296
39.

Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-based Analysis.

Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC.

Eur Urol. 2017 Nov 10. pii: S0302-2838(17)30911-9. doi: 10.1016/j.eururo.2017.10.020. [Epub ahead of print]

PMID:
29132713
40.

Inferior vena cava tumour thrombus and renal cell carcinoma.

Barbara DW, Broski SM, Leibovich BC, Mauermann WJ.

Can J Anaesth. 2018 May;65(5):588-589. doi: 10.1007/s12630-017-0999-5. Epub 2017 Nov 1. No abstract available.

PMID:
29094288
41.

Adjuvant Pazopanib Does Not PROTECT Against Recurrence of High-Risk, Initially Localized Renal Cell Cancer but Does Provide Novel Insights.

Stewart GD, Leibovich BC, Negrier S, Figlin RA.

J Clin Oncol. 2017 Dec 10;35(35):3895-3897. doi: 10.1200/JCO.2017.75.4242. Epub 2017 Oct 25. No abstract available.

PMID:
29068785
42.

Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging.

Atwell TD, Kurup AN, Boorjian SA, Schmitz JJ, Thompson RH, Leibovich BC, Schmit GD.

J Vasc Interv Radiol. 2017 Dec;28(12):1651-1657. doi: 10.1016/j.jvir.2017.08.008. Epub 2017 Oct 16.

PMID:
29042169
43.

Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma.

Antwi SO, Eckel-Passow JE, Diehl ND, Serie DJ, Custer KM, Wu KJ, Cheville JC, Thiel DD, Leibovich BC, Parker AS.

Int J Cancer. 2018 Feb 15;142(4):747-756. doi: 10.1002/ijc.31103. Epub 2017 Oct 28. Erratum in: Int J Cancer. 2018 Sep 1;143(5):E6.

44.

Should Urologists Abandon the Use of Mannitol During Partial Nephrectomy?

Shah PH, Leibovich BC, Lyon TD.

Eur Urol. 2018 Jan;73(1):60-61. doi: 10.1016/j.eururo.2017.09.017. Epub 2017 Oct 4. No abstract available.

PMID:
28985968
45.

Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis.

Bhindi B, Mason RJ, Haddad MM, Boorjian SA, Leibovich BC, Atwell TD, Weisbrod AJ, Schmit GD, Thompson RH.

Eur Urol. 2018 Feb;73(2):254-259. doi: 10.1016/j.eururo.2017.09.009. Epub 2017 Sep 28.

PMID:
28967553
46.

Long-term Follow-up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-confined Prostate Cancer With a Positive Surgical Margin.

Bhindi B, Carlson RE, Mason RJ, Schulte PJ, Gettman MT, Frank I, Tollefson MK, Thompson RH, Boorjian SA, Leibovich BC, Karnes RJ.

Urology. 2017 Nov;109:145-152. doi: 10.1016/j.urology.2017.06.054. Epub 2017 Aug 18.

PMID:
28823636
47.

Predictors of a Successful Urology Resident Using Medical Student Application Materials.

Thompson RH, Lohse CM, Husmann DA, Leibovich BC, Gettman MT.

Urology. 2017 Oct;108:22-28. doi: 10.1016/j.urology.2017.06.046. Epub 2017 Jul 24.

PMID:
28751165
48.

Surgical Management and Oncologic Outcomes of Recurrent Venous Tumor Thrombus after Prior Nephrectomy for Renal Cell Carcinoma.

Parker WP, Boorjian SA, Zaid HB, Cheville JC, Leibovich BC, Thompson RH.

Eur Urol Focus. 2016 Dec 15;2(6):625-630. doi: 10.1016/j.euf.2016.05.003. Epub 2016 Jul 7.

PMID:
28723495
49.

Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death.

Parasramka M, Serie DJ, Asmann YW, Eckel-Passow JE, Castle EP, Stanton ML, Leibovich BC, Thompson RH, Thompson EA, Parker AS, Ho TH, Joseph RW.

Eur Urol Focus. 2016 Dec 15;2(6):608-615. doi: 10.1016/j.euf.2016.03.008. Epub 2016 Apr 2.

PMID:
28723492
50.

Three-dimensional Printing for Renal Cancer and Surgical Planning.

Westerman ME, Matsumoto JM, Morris JM, Leibovich BC.

Eur Urol Focus. 2016 Dec 15;2(6):574-576. doi: 10.1016/j.euf.2016.12.009. Epub 2017 Jan 19.

PMID:
28723485

Supplemental Content

Loading ...
Support Center